课题基金 / 基金详情

Mechanisms of cyclooxygenase2 expression-induced by oxidized-LDL in VSMC

Mechanisms of cyclooxygenase2 expression-induced by oxidized-LDL in VSMC
氧化LDL诱导VSMC中环氧合酶2表达的机制
批准号:
13670736
负责人:
YAMAKAWA Tadashi
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

YAMAKAWA Tadashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In 2001, proliferation of vascular smooth muscle cells (VSMC) were found to be mediated through cyclooxygenase 2 (COX2) expression-induced by Oxidized LDL. We also identified that COX2 expression was dependent on the activation of p42/44MAPK and p38MAPK. In 2002, in order to elucidate the regulation of transcription of COX2 and novel pathways besides MAPKs, we performed following experiments. First, we examined the role of p42/44MAPK and p38MAPK on cox2 mRNA expression. We identified that p42/44MAPK was related with transcription of cox2 and p38MAPK was associated with the stabilization of cox2 mRNA. Second, Dr Eguchi found that mRNA expression of helix-loop helix Id3 aw well as p21WAP/Cip1 and p27Kip1 were enhanced by oxidized-LDL stimulation in VSMC. It is very interesting that all of them were cell cycle related genes. Therefore, we need to do further investigation of the signaling pathway of these genes-induced by oxidized-LDL to identify the mechanisms of growth of VSMC.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
T. Yamakawa et al.: "Lysophosphatidylcholine activates Extracellular Signal-Regulated Kinesis 1/2 through Reactive Oxygen Species in Rat Vascular Smooth Muscle Cells"Arteriosclerosis, Thrombosis, and Vascular Biology 22. 752-758 (2002)
T. Yamakawa 等人:“溶血磷脂酰胆碱通过大鼠血管平滑肌细胞中的活性氧激活细胞外信号调节运动 1/2”动脉硬化、血栓形成和血管生物学 22. 752-758 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y Yamakawa et al.: "Lysophosphatidylcholine activates Extracellular Signal-Regulated Kinases 1/2 through"Arteriosclerosis, Thrombosis, and Vascular Biology. 22. 752-758 (2002)
Y Yamakawa 等人:“溶血磷脂酰胆碱通过”动脉硬化、血栓形成和血管生物学激活细胞外信号调节激酶 1/2。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T Yamakawa et al.: "Lysophosphatidylcholine Inhibits Insulin-Induced Akt Activation Through Protein"Hypertension. 39. 508-512 (2002)
T Yamakawa 等人:“溶血磷脂酰胆碱通过蛋白质抑制胰岛素诱导的 Akt 激活”高血压。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T Yamakawa et al.: "Lysophosphatidylcholine activates Extracellular Signal-Regulated Kinases 1/2"Arteriosclerosis, Thrombosis, and Vascular Biology. 22. 752-758 (2002)
T Yamakawa 等人:“溶血磷脂酰胆碱激活细胞外信号调节激酶 1/2”动脉硬化、血栓形成和血管生物学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
7
    The elucidation of antihyperglycemic action mechanism in the liver and pancreatic beta cells of bile acid resin
    • 批准号:
      22590989
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      YAMAKAWA Tadashi
    • 依托单位:
    Effect of Dehydroepiandrosterone on Atherosclerosis in Apolipoprotein E-Deficient Mice
    • 批准号:
      18590820
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.43万
    • 财政年份:
      2006
    • 负责人:
      YAMAKAWA Tadashi
    • 依托单位:
    Studies for the Mechanisms of oxidized LDL-induced growth in vascular smooth muscle cells
    • 批准号:
      15590764
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2003
    • 负责人:
      YAMAKAWA Tadashi
    • 依托单位:
    国内基金
    海外基金
    基于AMPKα/p42/44(MAPK通路探讨脂联素抑制前列腺癌发生发展的机制研究
    • 批准号:
      2022J05323
    • 项目类别:
      省市级项目
    • 资助金额:
      8.0万元
    • 批准年份:
      2022
    • 负责人:
      程丽宪
    • 依托单位:
    FOXA1通过与EBP1 p42相互作用抑制肝细胞癌侵袭转移的机制研究
    • 批准号:
      2020A151501096
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2020
    • 负责人:
      陈逢生
    • 依托单位:
    基于TNF-α/CTRP9/p42/44MAPK信号通路探讨当归红芪超滤物干预重离子束致心肌细胞损伤的氧化应激机制
    • 批准号:
      81860786
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      34.0万元
    • 批准年份:
      2018
    • 负责人:
      赵信科
    • 依托单位:
    MCP-1对胰岛素抵抗和HDL胆固醇逆转运的影响及p42/44 MAPK调节机制
    • 批准号:
      81700397
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      孙润陆
    • 依托单位: